TRxADE HEALTH, Inc. (MEDS) Misses Q1 EPS by 5c

TRxADE HEALTH, Inc. (NASDAQ: MEDS) reported Q1 EPS of ($0.07), $0.05 worse than the analyst estimate of ($0.02). Revenue for the quarter came in at $2.2 million versus the consensus estimate of $2.75 million.

For earnings history and earnings-related data on TRxADE HEALTH, Inc. (MEDS) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• SVB & T Corporation (SVBT) Tops Q2 EPS by 275c
• Reading (RDI) Tops Q2 EPS by 4c